Analystreport

ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) had its price target lowered by analysts at Piper Sandler from $8.00 to $3.00.

ASLAN Pharmaceuticals Limited - American Depositary Shares  (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com